Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis is a research paper published in CHEST Journal (2023). On theSindex it has a DataRank of 1.0. It has been cited 31 times, with 28 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0.490
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 28 citers.
National Heart, Lung, and Blood Institute
Grant: R34HL138235
National Institutes of Health
MeSH Terms
Keywords